November 16, 2016 / 11:42 AM / in a year

BRIEF-Prometic receives clearance from Health Canada to proceed with its PBI-4050 placebo-controlled phase 2 clinical trial

Nov 16 (Reuters) - Prometic Life Sciences Inc

* Says phase 2 clinical trial on pbi-4050 expected to commence in Q4 2016

* Prometic receives clearance from Health Canada to proceed with its PBI-4050 placebo-controlled phase 2 clinical trial in patients with metabolic syndrome and type 2 diabetes Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below